ScholarIQanswers from OpenAlex & ORCID
Luis Fayad
ResearcherPublications, citations & collaboration network
Luis Fayad is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Luis Fayad have?
ScholarIQindexed works
Luis Fayad has 648 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Luis Fayad have?
ScholarIQcitation count
Luis Fayad has 21,168 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Luis Fayad?
ScholarIQh-index
Luis Fayad has an h-index of 75 in OpenAlex.
What is the i10-index of Luis Fayad?
ScholarIQi10-index
Luis Fayad has an i10-index of 251 in OpenAlex.
What is the ORCID of Luis Fayad?
ScholarIQorcid
The ORCID for Luis Fayad is on the source record.
What is the OpenAlex record for Luis Fayad?
ScholarIQopenalex
The OpenAlex for Luis Fayad is on the source record.
What are the most-cited papers on Luis Fayad?
ScholarIQmost cited works
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Qing Deng, Guangchun Han, Nahum Puebla‐Osorio, Man Chun John, Paolo Strati, Beth Chasen, Enyu Dai, Minghao Dang, Neeraj Jain, Haopeng Yang, Yuanxin Wang, Shaojun Zhang, Ruiping Wang, Runzhe Chen, Jordan Showell, Sreejoyee Ghosh, Sridevi Patchva, Qi Zhang, Ryan Sun, Frederick Hagemeister, Luis Fayad, Felipe Samaniego, Hans C. Lee, Loretta J. Nastoupil, Nathan Fowler, R. Eric Davis, Jason R. Westin, Sattva S. Neelapu, Linghua Wang, Michael R. Green
Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda, Tariq N. Aladily, H. Miles Prince, Rashmi Kanagal‐Shamanna, Daphne de Jong, Luis Fayad, Mitual Amin, Nisreen Haideri, Govind Bhagat, Glen S. Brooks, David A. Shifrin, Dennis P. O’Malley, Chan Y. Cheah, Carlos E. Bacchi, Gabrıela Gualco, Shiyong Li, John A. Keech, Ephram P. Hochberg, Matthew J. Carty, Summer E. Hanson, Eid B. Mustafa, Steven Sanchez, John T. Manning, Zijun Y. Xu‐Monette, Alonso R. Miranda, Patricia S. Fox, Roland L. Bassett, Jorge J. Castillo, Brady Beltrán, Jan Paul de Boer, Zaher Chakhachiro, Dongjiu Ye, Douglas Clark, Ken H. Young, L. Jeffrey Medeiros
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak, Liang Zhang, Fredrick Hagemeister, Sattva S. Neelapu, Felipe Samaniego, Peter McLaughlin, Michelle A. Fanale, Anas Younes, Fernando Cabanillas, Nathan Fowler, Kate J. Newberry, Luhong Sun, Ken H. Young, Richard E. Champlin, Larry W. Kwak, Lei Feng, Maria Badillo, Maria Teresa Bejarano, Kimberly Hartig, Wendy Chen, Yi‐Ming Chen, Catriona Byrne, Neda Bell, Jerome B. Zeldis, Jorge Romaguera